Streetbeat News

Analyst Ratings

PAHC

Phibro Animal Health (NASDAQ:PAHC) has received two bullish and two indifferent analyst ratings in the last quarter. The average 12-month price target for the company, according to four analysts, is $19.25, with a high of $21.00 and a low of $17.00. This average price target has increased by 6.94% over the past month.

Portfolio Pulse from Benzinga Insights

September 01, 2023 | 5:00 pm

BOKF

Over the past 3 months, 7 analysts have published indifferent opinions on BOK Financial (NASDAQ:BOKF) stock. The average 12-month price target for BOK Financial is $93.43, which has increased by 1.33% over the past month.

Portfolio Pulse from Benzinga Insights

September 01, 2023 | 5:00 pm

ESTC

Barclays has maintained its Overweight rating for Elastic (NYSE:ESTC) and increased its price target from $83.00 to $86.00. Elastic's shares have risen by 22.2% over the last 24 hours, trading at $75.62 per share. A move to $86.00 would represent a 13.73% increase from the current share price.

Portfolio Pulse from Benzinga Insights

September 01, 2023 | 5:00 pm

LTHM

Livent (NYSE:LTHM) has received somewhat bullish ratings from four analysts in the last quarter, with an average price target of $33.5, implying an upside from the current price of $21.795. This represents a 0.74% decrease from the previous average price target of $33.75.

Portfolio Pulse from Benzinga Insights

September 01, 2023 | 5:00 pm

CM

RBC Capital has maintained its Sector Perform rating for Canadian Imperial Bank (NYSE:CM) but lowered its price target from $72.00 to $67.00. The bank's shares are currently trading at $39.77, meaning the new target price would represent a 68.47% increase.

Portfolio Pulse from Benzinga Insights

September 01, 2023 | 5:00 pm

PGR

Progressive Inc.'s stock has increased by 7.02% over the past month and by 10.56% over the past year. The company's P/E ratio of 45.87 is significantly higher than the aggregate P/E ratio of the insurance industry (17.73), suggesting that the stock might be overvalued. However, the P/E ratio is just one of many metrics that investors should consider when making investment decisions.

Portfolio Pulse from Benzinga Insights

September 01, 2023 | 5:00 pm

CIEN

UBS has maintained its Neutral rating for Ciena (NYSE:CIEN) and raised its price target from $48.00 to $52.00. Ciena's shares are currently trading down 2.61% at $48.67 per share. A move to $52.00 would represent a 6.83% increase from the current share price.

Portfolio Pulse from Benzinga Insights

September 01, 2023 | 5:00 pm

IOT

In the last quarter, Samsara (NYSE:IOT) received 5 somewhat bullish and 3 indifferent ratings from analysts. The average price target is $30.25, slightly above the current price of $30.22. The average price target has increased by 12.54% over the past month.

Portfolio Pulse from Benzinga Insights

September 01, 2023 | 5:00 pm

ALB

Piper Sandler analyst Charles Neivert maintains an Overweight rating on Albemarle (NYSE:ALB), but lowers the price target from $275 to $255.

Portfolio Pulse from Benzinga Newsdesk

September 01, 2023 | 5:00 pm

ILMN

In the last quarter, Illumina (NASDAQ:ILMN) received various analyst ratings, with 5 being bullish, 3 somewhat bullish, 2 indifferent, and 1 bearish. The average 12-month price target for Illumina, according to 11 analysts, is $240.0, a decrease of 4.0% from the previous average price target of $250.00.

Portfolio Pulse from Benzinga Insights

September 01, 2023 | 5:00 pm